RxDoctor Payments Data

Christopher Title

Family · East Lansing, MINPI 1578068235

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 1,143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,859in general payments, 2019–2025

Across 1,143 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$5K
  • AbbVie$3K
  • Amgen$3K
  • UCB, Inc.$3K
  • AstraZeneca$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • plus $6K from 31 others

What the payments were for

  • Food & beverage$22,31098%
  • Education$5492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,859 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$17,084
Medicare patients
76
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept18$135,973
Leflunomide100$6,349
Hydroxychloroquine Sulfate105$4,944
MethotrexateMethotrexate Sodium64$3,489
Allopurinol127$1,556
ValacyclovirValacyclovir Hcl16$1,522
Sulfasalazine31$1,408
Prednisone139$1,094
Sulindac15$553
Levothyroxine Sodium44$441
Triamcinolone Acetonide20$330
Duloxetine Hcl18$208
Alendronate Sodium25$191
Trazodone Hcl11$175
Nabumetone12$168

Paid to pharmacies, not to this prescriber.

Other family in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →